---
title: "CRBP.US (CRBP.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/CRBP.US/news.md"
symbol: "CRBP.US"
name: "CRBP.US"
parent: "https://longbridge.com/en/quote/CRBP.US.md"
datetime: "2026-03-07T10:41:58.022Z"
locales:
  - [en](https://longbridge.com/en/quote/CRBP.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/CRBP.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/CRBP.US/news.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/CRBP.US/news.md) | [繁體中文](https://longbridge.com/zh-HK/quote/CRBP.US/news.md)


# CRBP.US (CRBP.US) — Related News

### [Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Wednesday When Compared To Competitors Despite Daily Gains](https://longbridge.com/en/news/277841854.md)
*2026-03-04T22:24:38.000Z*
> Corbus Pharmaceuticals Holdings Inc. (CRBP) saw its shares rise 2.56% to $8.42 on Wednesday, breaking a two-day losing s

### [Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors Despite Losses On The Day](https://longbridge.com/en/news/277526929.md)
*2026-03-02T22:20:54.000Z*
> Corbus Pharmaceuticals Holdings Inc. (CRBP) shares fell 2.57% to $8.35, ending a four-day winning streak, while the NASD

### [Revvity Inc. Stock Outperforms Competitors On Strong Trading Day](https://longbridge.com/en/news/277107168.md)
*2026-02-26T22:18:46.000Z*
> Revvity Inc. (RVTY) shares rose 1.48% to $99.01 on a mixed trading day, outperforming competitors like Danaher Corp. (DH

### [Corbus Pharmaceuticals Touts “Catalyst-Rich” 2026 With CRB-701 and CRB-913 Data Readouts Ahead](https://longbridge.com/en/news/277003496.md)
*2026-02-26T08:08:03.000Z*
> Corbus Pharmaceuticals (NASDAQ:CRBP) announced a "catalyst-rich" 2026 at Oppenheimer’s Healthcare Conference, highlighti

### [Corbus Highlights Diversified Oncology and Metabolic Pipeline Outlook](https://longbridge.com/en/news/276893644.md)
*2026-02-25T13:18:56.000Z*
> Corbus Pharmaceuticals (CRBP) provided an update on its diversified oncology and metabolic pipeline, featuring CRB-701, 

### [Corbus updates corporate presentation, details 2026 clinical and financial milestones](https://longbridge.com/en/news/276889638.md)
*2026-02-25T12:53:00.000Z*
> Corbus Pharmaceuticals updated its corporate presentation, revealing $173M in cash and key clinical milestones for 2026.

### [Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors On Strong Trading Day](https://longbridge.com/en/news/276795898.md)
*2026-02-24T22:23:30.000Z*
> Corbus Pharmaceuticals Holdings Inc. (CRBP) shares rose 2.83% to $7.63 on a strong trading day, outperforming competitor